Envoy Medical, Inc. (COCH)
(Delayed Data from NSDQ)
$2.25 USD
+0.01 (0.45%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $2.23 -0.02 (-0.89%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
COCH 2.25 +0.01(0.45%)
Will COCH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for COCH based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for COCH
Envoy Medical initiated with bullish view at Ascendiant, here's why
Envoy Medical’s Innovative Cochlear Implant Sparks Buy Rating Amidst Market Growth Potential
Northland Securities Sticks to Its Buy Rating for Envoy Medical (COCH)
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
Envoy Medical Announces Board Reshuffle and New Appointment